Nedaplatin
Term · Oncology and biomedicine · MLC-T-ONC-015459
A second-generation cisplatin analogue with antineoplastic activity. Containing a novel ring structure in which glycolate is bound to the platinum by a bidentate ligand, nedaplatin forms reactive platinum complexes that bind to nucelophillic groups in DNA, resulting in intrastrand and interstrand DNA cross-links, apoptosis and cell death. This agent appears to be less nephrotoxic and neurotoxic compared to both cisplatin and carboplatin.
| Identifier | MLC-T-ONC-015459 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | nedaplat |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015459",
"term": "Nedaplatin",
"field": "Oncology and biomedicine",
"definition": "A second-generation cisplatin analogue with antineoplastic activity. Containing a novel ring structure in which glycolate is bound to the platinum by a bidentate ligand, nedaplatin forms reactive platinum complexes that bind to nucelophillic groups in DNA, resulting in intrastrand and interstrand DNA cross-links, apoptosis and cell death. This agent appears to be less nephrotoxic and neurotoxic compared to both cisplatin and carboplatin.",
"synonyms": [
"nedaplat"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/nedaplatin/"
}
Record 11,658 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.